Profile data is unavailable for this security.
About the company
Premier, Inc. is a healthcare improvement company, uniting an alliance of over 4,350 United States hospitals and health systems and over 325,000 other providers and organizations to transform healthcare. Its segments include Supply Chain Services and Performance Services. The Supply Chain Services segment includes its group purchasing organization program, supply chain co-management, purchased services and direct sourcing activities. The Performance Services segment consists of three sub-brands: PINC AI, its technology and services platform, Contigo Health, its direct-to-employer business, and Remitra, its digital invoicing and payables automation business. It delivers a comprehensive technology-enabled platform that offers critical supply chain services, clinical, financial, operational and value-based care software as a service and clinical and enterprise analytics license, consulting services, performance improvement collaborative programs and third-party administrator services.
- Revenue in USD (TTM)1.28bn
- Net income in USD147.17m
- Incorporated2013
- Employees2.90k
- LocationPremier Inc13034 Ballantyne Corporate PlaceCHARLOTTE 28277United StatesUSA
- Phone+1 (704) 357-0022
- Fax+1 (302) 655-5049
- Websitehttps://www.premierinc.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10X Genomics Inc | 629.74m | -182.55m | 1.61bn | 1.26k | -- | 2.23 | -- | 2.55 | -1.53 | -1.53 | 5.26 | 5.97 | 0.6677 | 2.40 | 6.72 | 500,193.00 | -19.36 | -25.52 | -21.99 | -29.05 | 66.63 | 75.88 | -28.99 | -48.53 | 4.12 | -- | 0.00 | -- | 19.81 | 33.43 | -53.67 | -- | 49.15 | -- |
| AtriCure Inc | 447.57m | -38.92m | 1.74bn | 1.20k | -- | 3.74 | -- | 3.89 | -0.8322 | -0.8322 | 9.56 | 9.54 | 0.7365 | 1.63 | 8.41 | 372,977.50 | -6.40 | -3.72 | -7.35 | -4.10 | 74.79 | 74.36 | -8.70 | -7.64 | 2.59 | -13.76 | 0.1194 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
| Integra Lifesciences Holdings Corp | 1.56bn | -6.54m | 1.77bn | 3.95k | -- | 1.17 | 13.89 | 1.13 | -0.0881 | -0.0881 | 20.22 | 19.73 | 0.401 | 1.59 | 5.99 | 396,583.90 | -0.1677 | 3.33 | -0.2002 | 3.68 | 59.29 | 63.67 | -0.4182 | 7.99 | 0.7261 | 4.05 | 0.5428 | 0.00 | -1.03 | 0.9219 | -62.48 | 2.19 | -2.97 | -- |
| Patterson Companies, Inc. | 6.53bn | 168.41m | 1.79bn | 7.60k | 11.08 | 1.88 | 6.93 | 0.2736 | 1.83 | 1.83 | 71.22 | 10.80 | 2.27 | 5.86 | 15.35 | 859,640.70 | 5.84 | 1.13 | 10.15 | 1.81 | 21.03 | 20.98 | 2.57 | 0.5157 | 0.6723 | 7.91 | 0.4474 | 304.75 | 1.50 | 3.34 | -10.42 | 18.10 | 2.17 | 0.00 |
| Rxsight Inc | 128.29m | -30.69m | 1.82bn | 374.00 | -- | 6.54 | -- | 14.15 | -0.8194 | -0.8194 | 3.40 | 6.89 | 0.5212 | 1.99 | 6.32 | 343,029.40 | -12.47 | -- | -13.62 | -- | 68.44 | -- | -23.92 | -- | 11.71 | -- | 0.0005 | -- | 81.77 | -- | 27.19 | -- | -- | -- |
| Novocure Ltd | 577.74m | -149.78m | 1.85bn | 1.45k | -- | 5.12 | -- | 3.20 | -1.39 | -1.39 | 5.37 | 3.34 | 0.4879 | 3.59 | 8.74 | 397,617.30 | -12.65 | -7.74 | -20.29 | -8.95 | 76.42 | 77.22 | -25.93 | -14.69 | 1.44 | -- | 0.6446 | -- | -5.30 | 15.47 | -123.75 | -- | 32.19 | -- |
| Tandem Diabetes Care Inc | 854.35m | -126.78m | 2.02bn | 2.40k | -- | 8.49 | -- | 2.36 | -1.94 | -1.94 | 13.08 | 3.62 | 0.9004 | 2.90 | 8.23 | 355,979.60 | -13.36 | -10.08 | -17.47 | -12.23 | 49.79 | 51.77 | -14.84 | -11.59 | 2.32 | -- | 0.5945 | -- | -6.68 | 32.39 | -135.33 | -- | 76.81 | -- |
| Omnicell Inc | 1.06bn | -17.69m | 2.03bn | 3.66k | -- | 1.66 | 30.57 | 1.91 | -0.3917 | -0.3917 | 23.17 | 26.59 | 0.4704 | 5.90 | 4.06 | 291,563.30 | -0.7817 | 1.73 | -1.11 | 2.25 | 41.44 | 46.69 | -1.66 | 2.92 | 0.9529 | -- | 0.3172 | 0.00 | -11.48 | 7.82 | -460.68 | -- | 0.235 | -- |
| Premier Inc | 1.28bn | 147.17m | 2.15bn | 2.90k | 16.23 | 1.12 | 8.21 | 1.69 | 1.38 | 1.37 | 11.65 | 19.98 | 0.3562 | -- | 2.99 | 439,914.10 | 3.83 | 7.08 | 4.78 | 8.95 | 67.24 | 61.29 | 10.76 | 16.05 | -- | -- | 0.2771 | 27.32 | 0.7684 | 2.03 | -31.70 | -11.93 | -2.76 | -- |
| Conmed Corp | 1.29bn | 131.74m | 2.22bn | 4.00k | 16.96 | 2.37 | 10.88 | 1.72 | 4.23 | 4.23 | 41.38 | 30.21 | 0.555 | 1.71 | 5.58 | 322,029.00 | 5.68 | 0.8972 | 6.62 | 1.02 | 55.65 | 54.95 | 10.23 | 1.65 | 1.06 | 5.22 | 0.5021 | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
| Irhythm Technologies Inc | 560.03m | -150.66m | 2.31bn | 2.00k | -- | 32.22 | -- | 4.13 | -4.85 | -4.85 | 18.04 | 2.29 | 0.83 | 12.56 | 8.79 | 280,012.50 | -22.33 | -21.92 | -26.27 | -26.77 | 67.83 | 69.39 | -26.90 | -25.75 | 6.12 | -24.18 | 0.90 | -- | 19.90 | 27.32 | -6.24 | -- | 50.82 | -- |
| UFP Technologies Inc | 461.85m | 54.21m | 2.34bn | 3.09k | 43.55 | 7.11 | 34.79 | 5.06 | 7.00 | 7.00 | 59.64 | 42.89 | 0.8896 | 4.18 | 6.15 | 149,320.40 | 10.44 | 9.69 | 12.00 | 10.95 | 28.31 | 26.33 | 11.74 | 10.14 | 1.43 | 13.44 | 0.3919 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
| LeMaitre Vascular Inc | 213.03m | 41.32m | 2.38bn | 614.00 | 58.07 | 7.19 | 46.72 | 11.17 | 1.82 | 1.82 | 9.41 | 14.73 | 0.5992 | 1.11 | 7.59 | 346,952.80 | 11.62 | 9.02 | 12.66 | 9.93 | 68.34 | 65.83 | 19.40 | 15.45 | 5.52 | -- | 0.00 | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
| Quidelortho Corp | 2.82bn | -1.87bn | 2.55bn | 7.10k | -- | 0.799 | -- | 0.9044 | -27.89 | -27.89 | 42.04 | 47.42 | 0.3674 | 2.62 | 7.84 | 396,859.20 | -24.34 | 11.34 | -27.75 | 12.91 | 47.62 | 62.71 | -66.25 | 20.93 | 0.8134 | 0.7419 | 0.4446 | 0.00 | -8.21 | 41.83 | -101.84 | -- | 45.87 | -- |
| Enovis Corp | 2.00bn | -121.38m | 2.58bn | 6.55k | -- | 0.7745 | 17.63 | 1.29 | -2.21 | -2.17 | 36.43 | 59.61 | 0.4023 | 1.59 | 5.91 | 305,598.20 | -2.43 | -0.3569 | -2.66 | -0.41 | 56.96 | 48.19 | -6.03 | -1.06 | 1.12 | 0.9889 | 0.2876 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
| TransMedics Group Inc | 401.09m | 32.64m | 2.66bn | 584.00 | 84.50 | 12.68 | 52.79 | 6.64 | 0.9389 | 0.9389 | 11.60 | 6.25 | 0.5439 | 3.56 | 5.32 | 686,797.90 | 4.43 | -16.08 | 4.78 | -17.95 | 59.34 | 65.37 | 8.14 | -40.47 | 7.33 | -- | 0.7078 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
Data as of Nov 22 2024. Currency figures normalised to Premier Inc's reporting currency: US Dollar USD
51.77%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2024 | 11.81m | 12.15% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 11.27m | 11.59% |
| Pacer Advisors, Inc.as of 30 Sep 2024 | 5.99m | 6.16% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 5.63m | 5.79% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 3.97m | 4.09% |
| First Trust Advisors LPas of 30 Sep 2024 | 3.94m | 4.06% |
| American Century Investment Management, Inc.as of 30 Sep 2024 | 2.49m | 2.57% |
| Charles Schwab Investment Management, Inc.as of 30 Sep 2024 | 1.74m | 1.79% |
| Geode Capital Management LLCas of 30 Sep 2024 | 1.74m | 1.79% |
| Parametric Portfolio Associates LLCas of 30 Sep 2024 | 1.73m | 1.78% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
